RAXONE Film-coated tablet Ref.[9792] Active ingredients: Idebenone

Source: European Medicines Agency (EU)  Revision Year: 2020  Publisher: Santhera Pharmaceuticals (Deutschland) GmbH, Marie-Curie Strasse 8, 79539 Lรถrrach, Germany, Tel: +49 (0) 7621 1690 200, Fax: +49 (0) 7621 1690 201, Email: office@santhera.com

Product name and form

Raxone 150 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet.

Orange, round, biconvex film-coated tablet of 10 mm diameter, engraved with the Santhera logo on one side and ‘150’ on the other side.

Qualitative and quantitative composition

Each film-coated tablet contains 150 mg idebenone.

Excipients with known effect: Each film-coated tablet contains 46 mg of lactose (as monohydrate) and 0.23 mg of sunset yellow FCF (E110).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Idebenone

Idebenone is an anti-oxidant assumed to be capable of transferring electrons directly to complex III of the mitochondrial electron transport chain, thereby restoring cellular energy (ATP) generation under experimental conditions of complex I deficiency. Similarly, in LHON idebenone can transfer electrons directly to complex III of the electron transport chain, thereby bypassing complex I which is affected by all three primary mtDNA mutations causing LHON, and restoring cellular ATP generation.

List of Excipients

Tablet core:

Lactose monohydrate
Cellulose, microcrystalline
Croscarmellose sodium
Povidone (K25)
Magnesium stearate
Silica, colloidal anhydrous

Film-coating:

Macrogol (3350)
Poly(vinyl alcohol)
Talc
Titanium dioxide
Sunset yellow FCF (E110)

Pack sizes and marketing

White high-density polyethylene bottles with white polypropylene child-resistant tamper-evident twist-off caps containing 180 film-coated tablets.

Marketing authorization holder

Santhera Pharmaceuticals (Deutschland) GmbH, Marie-Curie Strasse 8, 79539 Lรถrrach, Germany, Tel: +49 (0) 7621 1690 200, Fax: +49 (0) 7621 1690 201, Email: office@santhera.com

Marketing authorization dates and numbers

EU/1/15/1020/001

Date of first authorisation: 8 September 2015

Drugs

Drug Countries
RAXONE Austria, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom, South Africa

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.